Achieve Life Sciences is a specialty pharmaceutical company committed to advancing cytisine as a smoking cessation aid to overcome the global nicotine addiction epidemic.
Cytisine is a plant-based alkaloid with a high binding affinity to the α4β2 nicotine receptor. Over the past 15 years, it is estimated that over 20 million people have used cytisine to help combat nicotine addiction. Achieve’s focus is address the global smoking health epidemic by making cytisine widely available. Click here to learn more about Achieve and Cytisine